NSE - Delayed Quote INR
Ipca Laboratories Limited (IPCALAB.NS)
At close: 3:29 PM GMT+5:30
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 14 | 13 |
| Avg. Estimate | 5 | 0 | 36.14 | 47.07 |
| Low Estimate | 5 | 0 | 30.5 | 40.1 |
| High Estimate | 5 | 0 | 47.26 | 59.1 |
| Year Ago EPS | 6.42 | 5.72 | 21.57 | 36.14 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | -- | 14 | 13 |
| Avg. Estimate | 21.62B | -- | 90.25B | 103.53B |
| Low Estimate | 20.31B | -- | 81.29B | 100.01B |
| High Estimate | 22.25B | -- | 93.59B | 106.99B |
| Year Ago Sales | 15.88B | -- | 61.66B | 90.25B |
| Sales Growth (year/est) | 36.20% | -- | 46.40% | 14.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 4.8 | 7.1 | 5.6 | 5.1 |
| EPS Actual | 6.42 | 5.72 | 7.09 | 2.35 |
| Difference | 1.62 | -1.38 | 1.49 | -2.75 |
| Surprise % | 33.80% | -19.40% | 26.60% | -53.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 5 | 0 | 36.14 | 47.07 |
| 7 Days Ago | 5 | 0 | 36.14 | 47.07 |
| 30 Days Ago | 0 | 0 | 36.13 | 50.9 |
| 60 Days Ago | 0 | 0 | 40.01 | 48.62 |
| 90 Days Ago | 0 | 0 | 40.01 | 48.62 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | IPCALAB.NS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -22.10% | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 11.80% |
| Current Year | 67.50% | -- | -- | 2.20% |
| Next Year | 30.20% | -- | -- | 12.50% |
| Next 5 Years (per annum) | 44.70% | -- | -- | 11.03% |
| Past 5 Years (per annum) | -7.15% | -- | -- | -- |
Related Tickers
LAURUSLABS.BO Laurus Labs Limited
488.85
+0.28%
ZYDUSLIFE.NS Zydus Lifesciences Limited
988.45
-1.59%
LUPIN.BO Lupin Limited
2,180.15
-0.39%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,725.15
+1.52%
ALKEM.NS Alkem Laboratories Limited
5,670.35
-2.21%
AUROPHARMA.NS Aurobindo Pharma Limited
1,396.95
-0.73%
GLAND.NS Gland Pharma Limited
1,832.85
+13.78%
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,184.15
-0.51%
LUPIN.NS Lupin Limited
2,181.75
-0.30%
PPLPHARMA.BO Piramal Pharma Limited
273.60
-0.78%